FBXW7 inhibits metastasis and stemness of HCC via inducing  chromodomain helicase DNA binding protein 3 (CHD3) degradation, thereby enhancing sensitivity to oxaliplatin (39). Here, FBXW7 is linked to hepatocellular carcinoma.